Kapat
Popüler Videolar
Moods
Türler
English
Türkçe
Popüler Videolar
Moods
Türler
Turkish
English
Türkçe
Biosimilars Part 2: Regulatory and Current Status
13:25
|
Loading...
Download
Lütfen bekleyiniz...
Type
Size
İlgili Videolar
Biosimilars Part 2: Regulatory and Current Status
13:25
|
Dr. Rugo Discusses the Regulatory Process Behind Biosimilars
1:37
|
Biosimilars: what oncologists need to know
5:16
|
Biosimilars and the Issue of Interchangeability
4:53
|
Biosimilars: Part II | Colby Evans, MD | USA
10:26
|
The biosimilar regulatory pathway
4:05
|
Regulatory Pathway for Biosimilars
14:19
|
The regulation of biosimilars
1:32
|
How were biosimilars discussed at ESMO 2017?
1:01
|
Differentiating Biosimilars From Generic Drugs
3:32
|
Biosimilars | What is a Biosimilar? | Gastrointestinal Society
8:07
|
Biosimilars
4:33
|
Interchangeability 101 - Biosimilars & Interchangeable Biologics
2:46
|
Biosimilars and Biologics
38:15
|
Biosimilars Part 1: History and Biology
18:00
|
Advantages of using biosimilars
1:42
|
What are biosimilars? How do they work for arthritis?
3:45
|
The Complexity of Choosing Biosimilars in Oncology
5:56
|
Professor Angela Thomas: "Regulation of biologics & biosimilars"
39:16
|
Innovative Biosimilars Development Strategies
55:44
|
Copyright. All rights reserved © 2025
Rosebank, Johannesburg, South Africa
